Abstract
Anti‐CEA, anti‐vimentin, CAM5.2, BerEp4, Leu‐M1 and anti‐EMA were applied to effusions from 36 mesotheliomas, 53 adenocarcinomas and 24 reactive mesothelial proliferations. Stepwise logistic regressi...